Johns Hopkins Bloomberg School of Public Health

Johns Hopkins produces about 50,000 mosquitoes a week.

The director of Hopkins' Berman Institute of Bioethics discusses how medical tech is impacting the ways we make our babies. An estimated 2% of US-born babies are now conceived in labs, as part of an in-vitro fertilization industry worth more than $23 billion.

The city's flagship violence interruption program has been effective in curbing crime, says a new report by Hopkins' Center for Gun Violence Solutions. Lead author, Dr. Daniel Webster, joins us.

The study, led by researchers at the Johns Hopkins Bloomberg School of Public Health, focuses on harassment cases in the early months of the pandemic.

The senior scholar at Hopkins' Center for Health Security discusses competing theories on the origins of the COVID-19 virus, and recommended public health precautions.

Two leading voices on the issue of intimate partner violence discuss how the problem has been exacerbated by the pandemic, and how national policies can help survivors cope.

A new report co-authored by today's guests finds serious public health impacts from the city's inadequate bus & rail system.

Companies are beginning to bring employees back to the office after more than a year of remote work. But as COVID-19 vaccination rates slow and the Delta variant spreads, a return to work may mean adjusting to a new normal.

The Hopkins senior scholar discusses the latest surge in COVID infections, and explains a technical point in a Republican senator's allegations yesterday against Dr. Fauci.

In Baltimore, and across the country, supply now outweighs demand for the COVID-19 vaccine.That has led city health officials to shift their strategy to reach their goal of vaccinating 80% of the population by February.